{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T07:35:03Z","timestamp":1789457703018,"version":"build-2803163510"},"reference-count":18,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.3892\/or.2017.5422","type":"journal-article","created":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T07:21:22Z","timestamp":1486106482000},"page":"1573-1578","source":"Crossref","is-referenced-by-count":13,"title":["First description of a double heterozygosity for BRCA1 and BRCA2 pathogenic variants in a French metastatic breast cancer patient: A case report"],"prefix":"10.3892","volume":"37","author":[{"given":"Guillaume","family":"Meynard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Mansi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Lebahar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Villanueva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Klajer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Calcagno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Vivalta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Chaix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Agn\u00e8s","family":"Collonge-Rame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Populaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Paule","family":"Algros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prudence","family":"Colpart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Neidich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Pivot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsa","family":"Curtit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2017,2,3]]},"reference":[{"key":"key20180107224159_b1-or-37-03-1573","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10689-007-9154-8","article-title":"Familial breast cancer: Double heterozygosity for BRCA1 and BRCA2 mutations with differing phenotypes","volume":"7","author":"Smith","year":"2008","journal-title":"Fam Cancer"},{"key":"key20180107224159_b2-or-37-03-1573","doi-asserted-by":"crossref","first-page":"D992","DOI":"10.1093\/nar\/gkr1160","article-title":"French BRCA GGC Consortium: Description and analysis of genetic variants in French hereditary breast and ovarian cancer families recorded in the UMD-BRCA1\/BRCA2 databases","volume":"40","author":"Caputo","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"key20180107224159_b3-or-37-03-1573","volume-title":"Oncog\u00e9n\u00e9tique en 2014 - Consultations, laboratoires et prise en charge - reference: APPDECONCOG15"},{"key":"key20180107224159_b4-or-37-03-1573","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/1521-1878(200008)22:8<728::AID-BIES6>3.0.CO;2-B","article-title":"Roles of BRCA1 and its interacting proteins","volume":"22","author":"Deng","year":"2000","journal-title":"BioEssays"},{"key":"key20180107224159_b5-or-37-03-1573","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nrc3181","article-title":"BRCA1 and BRCA2: Different roles in a common pathway of genome protection","volume":"12","author":"Roy","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"key20180107224159_b6-or-37-03-1573","volume-title":"GeneReviews(\u00ae) [Internet]","author":"Petrucelli","year":"2016"},{"key":"key20180107224159_b7-or-37-03-1573","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1634\/theoncologist.9-1-13","article-title":"Recognition and management of hereditary breast cancer syndromes","volume":"9","author":"Thull","year":"2004","journal-title":"Oncologist"},{"key":"key20180107224159_b8-or-37-03-1573","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/S1470-2045(14)70444-9","article-title":"Maintenance capecitabine and bevacizumab versus bevacizumab alone after initial first-line bevacizumab and docetaxel for patients with HER2-negative metastatic breast cancer (IMELDA): A randomised, open-label, phase 3 trial","volume":"15","author":"Gligorov","year":"2014","journal-title":"Lancet Oncol"},{"key":"key20180107224159_b9-or-37-03-1573","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1136\/jmg.2004.027243","article-title":"Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutations","volume":"42","author":"Leegte","year":"2005","journal-title":"J Med Genet"},{"key":"key20180107224159_b10-or-37-03-1573","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1075-122X.2006.00245.x","article-title":"Double heterozygotes for non-Caucasian families with mutations in BRCA-1 and BRCA-2 genes","volume":"12","author":"Choi","year":"2006","journal-title":"Breast J"},{"key":"key20180107224159_b11-or-37-03-1573","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1086\/301903","article-title":"Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients","volume":"63","author":"Fodor","year":"1998","journal-title":"Am J Hum Genet"},{"key":"key20180107224159_b12-or-37-03-1573","first-page":"467","article-title":"The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations","volume":"10","author":"Satagopan","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key20180107224159_b13-or-37-03-1573","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/jnci\/91.11.943","article-title":"Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer","volume":"91","author":"Peto","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"key20180107224159_b14-or-37-03-1573","first-page":"486","article-title":"A common BRCA1 mutation in Norwegian breast and ovarian cancer families?","volume":"59","author":"Andersen","year":"1996","journal-title":"Am J Hum Genet"},{"key":"key20180107224159_b15-or-37-03-1573","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/ng1294-392","article-title":"Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families","volume":"8","author":"Simard","year":"1994","journal-title":"Nat Genet"},{"key":"key20180107224159_b16-or-37-03-1573","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1086\/302530","article-title":"Penetrances of BRCA1 1675delA and 1135insA with respect to breast cancer and ovarian cancer","volume":"65","author":"D\u00f8rum","year":"1999","journal-title":"Am J Hum Genet"},{"key":"key20180107224159_b17-or-37-03-1573","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.3892\/ijo.2012.1595","article-title":"Novel BRCA1 and BRCA2 pathogenic mutations in Slovene hereditary breast and ovarian cancer families","volume":"41","author":"Novakovi\u0107 S, Milatovi\u0107","year":"2012","journal-title":"Int J Oncol"},{"key":"key20180107224159_b18-or-37-03-1573","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.maturitas.2013.09.012","article-title":"Central European BRCA2 mutation carriers: Birth cohort status correlates with onset of breast cancer","volume":"77","author":"Tea","year":"2014","journal-title":"Maturitas"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2017.5422\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T17:53:42Z","timestamp":1515347622000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2017.5422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,3]]},"references-count":18,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,2,3]]},"published-print":{"date-parts":[[2017,3]]}},"alternative-id":["10.3892\/or.2017.5422"],"URL":"https:\/\/doi.org\/10.3892\/or.2017.5422","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,3]]}}}